Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 21, 2004, Pages 5423-5426

  Mazier, Claire ^a   Jaouen, Maryse ^a   Sari, Marie Agnès ^a   Buisson, Didier ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; CAREBASTINE; DRUG METABOLITE; EBASTINE; FEXOFENADINE; PEPTONE; PHENYL GROUP; TERFENADINE;

ABSIDIA; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG OXIDATION; MICROORGANISM; NONHUMAN; SOYBEAN; STREPTOMYCES; STREPTOMYCES PLATENSIS;

ABSIDIA; BIOTRANSFORMATION; BUTYROPHENONES; CUNNINGHAMELLA; HISTAMINE H1 ANTAGONISTS; OXIDATION-REDUCTION; PIPERIDINES; STREPTOMYCES GRISEUS; TERFENADINE;

ABSIDIA; ABSIDIA CORYMBIFERA; GLYCINE MAX; MAMMALIA; STREPTOMYCES; STREPTOMYCES PLATENSIS;

EID: 5344251671     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.076     Document Type: Article

References (31)

1. A. Markham, and A. Wagstaff Drugs 55 1998 269 274
2. B.P. Monahan, C.L. Ferguson, E.S. Killeavy, B.K. Lloyd, J. Troy, and L.R.J. Cantilena J. Am. Med. Ass. 266 1991 2375 2376
3. S. Pohjola-Sintonen, M. Viitasalo, and L. Toivonen Eur. J. Clin. Pharm. 45 1993 191 193
4. Fexofenadine: Allegra, carebastine: Ebastel
5. Q.K. Fang, C.H. Senanayake, H.S. Wilkinson, S.A. Wald, and H. Li Tetrahedron Lett. 39 1998 2701 2704
6. R.V. Smith, and J. Rosazza Biotech. Bioeng. 17 1975 785
7. R.V. Smith, and J. Rosazza J. Pharm. Sci. 64 1975 1737 1759
8. R. Azerad Adv. Biochem. Eng./Biotechnol. 63 1999 169 218
9. Schwartz, H.; Böttcher, H. U.S. Patent 5,204,249, 1993
10. H. Schwartz, A. Liebig-Weber, H. Hochstätter, and H. Böttcher Appl. Microbiol. Biotechnol. 44 1996 731 735
11. Azerad, R.; Biton, J.; Lacroix, I. WO Patent 99/47693, 1999
12. Michels, P. C.; Zirbes, E. L. U.S. Patent 2002/0087003, 2002
13. Meiwes, J.; Worm, M. U.S. Patent 5,990,127, 1993
14. G. Schmitz, D. Franke, S. Stevens, R. Takors, D. Weuster-Botz, and C. Wandrey J. Mol. Cat. B: Enz. 10 2000 313 324
15. S.G. Jezquel J. Mol. Cat. B: Enz. 5 1998 371 377
16. F.S. Sariaslani, and J.P. Rosazza Appl. Environ. Microbiol. 49 1983 451 452
17. H. Schwartz, R.E. Licht, and H.E. Radunz Appl. Microbiol. Biotechnol. 40 1993 382 385
18. F.S. Sariaslani, and D.A. Kunz Biochem. Biophys. Res. Commun. 141 1986 405 410
19. Liquid culture media containing (g/L) glucose 16, yeast extract 4, malt extract 10 (YM medium) and glucose 16, yeast extract 4, malt extract 10 and soybean peptones 5 (YMS medium)
20. The microorganisms were cultured in a 250 mL flask containing 100 mL of medium at 30°C in rotatory shaker (200 rpm). After 60 h substrate was added (20 mg) in DMF (0.2 mL) and the incubations were maintained at 30°C with orbital shaking and samples (1 mL) were withdrawn in 24 h intervals. Biomass was sedimented (15 min, 13,500 rpm), supernanants were micro-filtered (0.45 μm) and the filtrates were analyzed by HPLC
21. 4, concentrated and the extracts were reconstituted in acetonitrile for HPLC analysis
22. 3OD 250 MHz) 1.2 (6H, s), 1.6-1.8 (6H, m), 1.8-2.0 (6H, m), 2.6 (1H, s), 3.3 (2H, s), 3.6 (2H, s), 7.1 (2H, d, J = 7 Hz), 7.2 (6H, m), 7.5 (6H, m)
23. T.-M. Chen, K.Y. Chan, J.E. Coutant, and R.A. Okerlolm J. Pharm. Biomed. Anal. 9 1991 929 933
24. M. Jurima-Romet, K. Crawford, T. Cyr, and T. Inaba Drug Metab. Dispos. 22 1994 849 857
25. R.B. Silverman The Organic Chemistry of Enzyme-Catalysed Reactions 2002 Academic Press San Diego
26. F.P. Guengerich Chem. Res. Toxicol. 14 2001 611 650
27. K.H.J. Ling, G.A. Leeson, S.D. Burmaster, R.H. Hook, M.K. Reith, and L.K. Cheng Drug Metab. Dispos. 23 1995 631 636
28. T. Hashizume, S. Imaoka, M. Mise, Y. Terauchi, T. Fujii, H. Miyazaki, T. Kamataki, and Y. Funae J. Pharmacol. Exp. Ther. 300 2002 298 304
29. S. Othman, V. Mansuy-Mouries, C. Bensoussan, P. Battioni, and D. Mansuy C. R. Acad. Sci. Paris, Série II C 3 2000 751 755
30. 3OH 9:1 containing 1% of acetic acid afforded carebastine (164 mg, 86% yield). Mp 173-175°C
31. 3OH 9:1 containing 1% of acetic acid afforded fexofenadine (195 mg, 92% yield). Mp 193-195°C